- Home
- HBB vs OSUR Comparison
HBB vs OSUR Comparison
Compare HBB & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- OSUR
- Stock Information
- Founded
- HBB 1904
- OSUR 2000
- Country
- HBB United States
- OSUR United States
- Employees
- HBB N/A
- OSUR N/A
- Industry
- HBB Home Furnishings
- OSUR Medical/Dental Instruments
- Sector
- HBB Consumer Discretionary
- OSUR Health Care
- Exchange
- HBB Nasdaq
- OSUR Nasdaq
- Market Cap
- HBB 292.6M
- OSUR 289.4M
- IPO Year
- HBB 2017
- OSUR 1986
- Fundamental
- Price
- HBB $17.09
- OSUR $3.64
- Analyst Decision
- HBB
- OSUR Hold
- Analyst Count
- HBB 0
- OSUR 2
- Target Price
- HBB N/A
- OSUR $5.50
- AVG Volume (30 Days)
- HBB 52.5K
- OSUR 1.0M
- Earning Date
- HBB 10-30-2024
- OSUR 11-06-2024
- Dividend Yield
- HBB 2.68%
- OSUR N/A
- EPS Growth
- HBB 107.04
- OSUR N/A
- EPS
- HBB 1.88
- OSUR 0.15
- Revenue
- HBB $647,834,000.00
- OSUR $224,263,000.00
- Revenue This Year
- HBB $4.60
- OSUR N/A
- Revenue Next Year
- HBB N/A
- OSUR N/A
- P/E Ratio
- HBB $8.63
- OSUR $24.13
- Revenue Growth
- HBB 5.30
- OSUR N/A
- 52 Week Low
- HBB $14.34
- OSUR $3.58
- 52 Week High
- HBB $31.78
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- HBB 34.89
- OSUR 39.12
- Support Level
- HBB $15.90
- OSUR $3.76
- Resistance Level
- HBB $17.07
- OSUR $3.70
- Average True Range (ATR)
- HBB 0.89
- OSUR 0.17
- MACD
- HBB 0.11
- OSUR -0.02
- Stochastic Oscillator
- HBB 30.13
- OSUR 10.00
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.